openPR Logo
Press release

In-vitro Diagnostics Market report for 2018-2024 Eminent Players - Abbott, Becton Dickinson, BioRad, BioMerieux, Cephied (Danaher), Grifols, Johnson & Johnson, Luminex, LivaNova (Sorin), Ortho Clinical Diagnostics, F. Hoffmann-La Roche, Siemens, Thermo Fi

01-23-2019 11:09 AM CET | Health & Medicine

Press release from: Global Market Insights, Inc.

In-vitro Diagnostics Market Trends Growth Share Forecast Report 2024

In-vitro Diagnostics Market Trends Growth Share Forecast Report 2024

Global in-vitro diagnostics market to witness massive demand from infectious disease treatment applications over 2018-2024.

With incredible rise in the occurrence of diseases all around the world, in-vitro diagnostics (IVD) market has gained substantial momentum owing to its significance in detecting varied medical conditions and to expedite treatments. Different tests performed on human blood or tissue samples assist medical professionals to monitor the health of patients and treat, cure or prevent diseases. Prevalence of cancer, diabetes, autoimmune diseases, hepatitis, kidney disorders and a large number of infectious diseases have immensely transformed the in-vitro diagnostics industry landscape, along with influencing vital technological developments. Valued at nearly USD 62.8 billion in 2017, the global in-vitro diagnostics market has been witnessing massive expansion in the diagnosis and treatment of infectious diseases among the growing geriatric population.

Request sample copy of this report @

According to WHO estimates, the total population of people aged 60 years or more, will almost double from 900 million in 2015 to approx. 2 billion in 2050. It is a known fact that older people have lower immune systems and are more prone to getting infected, requiring consistent testing for diseases and necessitating the in-vitro diagnostics industry intervention. Mounting cases of infections in younger patients have also mandated the use of efficient diagnostic processes for recognizing and managing the diseases. Heavy R&D investments by healthcare companies and medical institutes have resulted in the discovery of several techniques for testing infections that cause respiratory disorders, diarrheal problems, tuberculosis and AIDS. Infectious diseases are a leading cause of fatalities worldwide and the need for appropriate methods of identifying and dealing with them will profusely advance the in-vitro diagnostics market.

As each disease is attributed to different causes, no unique method can be applied to test for every kind of infection. Considered to be one of the most advanced technology for testing available in the in-vitro diagnostics market, molecular diagnostics has grabbed the attention of key industry players who are seeking to capitalize on its extensive application scope. Becoming a go-to solution in clinical testing for infections, cancers and other disorders, molecular diagnostics has allowed for improved and faster detection of harmful agents in the blood stream. Molecular testing is able to detect even minute amounts of infectious elements in the body, enabling the identification of diseases faster than what was previously possible. Increasingly deployed in detecting infectious diseases as it is a less invasive technique in comparison to performing biopsies, molecular diagnostics technology has presented an extremely lucrative vertical within the in-vitro diagnostics market.

Make Inquiry about this report @

Elaborating on the potential of molecular diagnostics for managing infections, further WHO reports show that three categories of infectious diseases had been ranked in the top ten causes of deaths worldwide in 2016, namely tuberculosis, diarrheal diseases and lower respiratory infections. Tuberculosis (TB), in particular, had resulted in over 1.7 million deaths from the total of 10.4 million TB cases recorded in the year. Mostly affecting the lungs, TB easily spreads through air and inhaling only a small amount of infectious germs can cause the disease to build up. As such, the in-vitro diagnostics industry has experienced rapid progress in development of efficient testing solutions for early detection of this curable airborne disease. Notable industry collaborations have permitted the advent of affordable and easily accessible molecular diagnostic services to prevent the spread of TB and other infectious illnesses.

A reputed medical research foundation, LifeArc and the University of St Andrews Infection Group recently unveiled a new molecular diagnostic test, which they collaboratively developed for detecting and quantifying TB bacteria among affected patients. The Molecular Bacterial Load Assay (MBLA) test will purportedly use molecular techniques to count the live bacteria and the process is up to get CE-marked so that it can be made available to patients in every region. It is important to detect the onset of TB early and the MBLA is designed to achieve results within hours what traditional methods did in weeks. The in-vitro diagnostics market will largely benefit from the application of molecular diagnostics in treating TB, since international health agencies and governments have committed themselves towards eradicating the TB epidemic by 2030.

All in all, the in-vitro diagnostics industry has made unequivocal contributions towards diagnosing infectious diseases and enabled doctors to create targeted therapies and treatments for patients. Convenient access to superior quality equipment and the emergence of integrated monitoring technologies will further drive the in-vitro diagnostics market, which consists of leading healthcare companies like Abbot, BioRad, Cepheid, Danaher, Johnson & Johnson, Roche Diagnostics, Siemens and Qiagen.

Report Content

Chapter 1. Methodology
1.1. Methodology
1.2. Market definitions
1.3. Forecast parameters
1.4. Data sources
1.4.1. Secondary Paid sources Unpaid sources
1.4.2. Primary

Chapter 2. Executive Summary
2.1. In-vitro diagnostics industry 3600 synopsis, 2013 - 2024
2.1.1. Business trends
2.1.2. Type trends
2.1.3. Technology trends
2.1.4. Application trends
2.1.5. End-user trends
2.1.6. Regional trends

Chapter 3. In-vitro Diagnostics Industry Insights
3.1. Industry segmentation
3.2. Industry landscape, 2013 - 2024
3.3. Industry impact forces
3.3.1. Growth drivers Growing rate of healthcare infections particularly in North America Increasing adoption rate of automated diagnostic machine & equipment in Europe Rising geriatric population preferring personalized medicines in Asia Pacific Surging number of pathology labs and services equipped with advanced diagnostics machine Increasing awareness regarding viral disease detection in the U.S.
3.3.2. Industry pitfalls and challenges Excessive cost of diagnosis service
3.4. Growth potential analysis
3.4.1. By type
3.4.2. By technology
3.4.3. By application
3.4.4. By end-user
3.5. Regulatory landscape
3.5.1. U.S.
3.5.2. Europe
3.6. Porter’s analysis
3.7. Competitive landscape, 2017
3.7.1. Strategy dashboard
3.8. PESTEL analysis

Chapter 4. In-vitro Diagnostics Market, By Type
4.1. Key segment trends
4.2. Product
4.2.1. Market size, by region, 2013-2024 (USD Million)
4.2.2. Reagents & kits Market size, by region, 2013-2024 (USD Million)
4.2.3. Instruments Market size, by region, 2013-2024 (USD Million)
4.3. Service
4.3.1. Market size, by region, 2013-2024 (USD Million)
4.3.2. Software Market size, by region, 2013-2024 (USD Million)
4.3.3. Testing services Market size, by region, 2013-2024 (USD Million)

Global Market Insights, Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider; offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy and biotechnology.

Arun Hegde
Corporate Sales, USA
Global Market Insights, Inc.
Phone: 1-302-846-7766
Toll Free: 1-888-689-0688
Blog :

This release was published on openPR.

Permanent link to this press release:

Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release In-vitro Diagnostics Market report for 2018-2024 Eminent Players - Abbott, Becton Dickinson, BioRad, BioMerieux, Cephied (Danaher), Grifols, Johnson & Johnson, Luminex, LivaNova (Sorin), Ortho Clinical Diagnostics, F. Hoffmann-La Roche, Siemens, Thermo Fi here

News-ID: 1524932 • Views: 241

More Releases from Global Market Insights, Inc.

Hypochlorite Bleaches Market to hit US$ 300 Mn 2025 | Top Key Players like Adity …
As per the research report by Global Market Insights, Inc., Global Hypochlorite Bleaches Market to cross USD 300 million by 2025 and grow at 3.4% CAGR from 2019 to 2025. It has been projected that the Global hypochlorite bleaches market is expected to reach a consumption of around 485-kilo tons by 2025. Water scarcity as well as rising water costs have led to more emphasis being laid on water recycling and
Feminine Hygiene Products Market: Growing awareness regarding intimate health in …
Global Market Insights, Inc., announces an ongoing comprehensive report on the Feminine Hygiene Products Market. One of the most hushed topics across the world is female hygiene, the negligence of which results in several diseases. Studies claim that nearly 30% to 60 % women across the globe develop urinary tract infection once in their lifetime, mainly due to negligence in proper intimate hygiene. Dearth of knowledge regarding the negative consequences of
Examination Gowns Market 2020 business trends & growth opportunities to 2026
Global Market Insights, Inc., announces an ongoing comprehensive report on the Examination Gowns Market. The exposure to various kinds of hospital acquired infections has led to a spate of health problems for the healthcare professionals as well has the patients. In this regard, experts have been massively shifting to adoption of personal protective equipment or clothing, examination gowns, protecting them from all kinds of infections. These gowns are present in the
Nonwoven Packaging Market to witness increased demand from pharmaceutical sector …
Global Market Insights, Inc., announces an ongoing comprehensive report on the Nonwoven Packaging Market. With the world struggling to fight against negative consequences of industrialization and increased carbon emissions, nonwovens or nonwoven fabrics have emerged as an intrinsic solution for all ecological imbalances across the globe. These fabrics are made from staple fiber and long fibers, merged together by chemical, heat, or mechanical treatment. These are generally used in textile manufacturing

All 5 Releases

More Releases for Diagnostics

Influenza Diagnostics Market – Widening industry demand 2025 | DiaSorin, Roche …
Global Influenza Diagnostics Market: Snapshot The global market for influenza diagnostics is slated to expand at a promising pace in the next few years as the incidences of influence are rising at a massive pace on the globe front. A common illness of the respiratory system, the condition is responsible for between 250,000 to 500,000 deaths across the globe every year. As the virulent spread of the condition creates increased concerns
Demand for Rapid Diagnostics Tests Trending the Pneumonia Diagnostics Market
The World Health Organization estimates that pneumonia accounted for 16% of all deaths of children below the age of 5 years – more than 920,000 in 2015. The WHO states that the cost of pneumonia antibiotic treatment in the same year for child survival and newly born babies is roughly US$ 110 million annually. Therefore, there is a pressing need to analyse the pneumonia diagnostics market. In an upcoming report
Cancer Diagnostics Market : World Cancer Diagnostics Market Segmentation Analysi …
UpMarketResearch offers a latest published report on “Global Cancer Diagnostics Market Industry Analysis and Forecast 2018-2023” delivering key insights and providing a competitive advantage to clients through a detailed report. The report contains 117 pages which highly exhibits on current market analysis scenario, upcoming as well as future opportunities, revenue growth, pricing and profitability. The report begins with the overview of the Cancer Diagnostics market and updates the users about
Europe Transplant Diagnostics Market
The Europe Transplant Diagnostics Market Report is an upcoming report from Data Bridge Market Research. The new market report contains data for historic years 2015, the base year of calculation is 2017 and the forecast period is 2018 to 2025. Transplant diagnostics are the diagnostics tests performed while relocating organ in order to treat organ failure such as liver, pancreas, lungs, kidney, and heart. These tests are widely performed by skilled
Global Rapid Diagnostics Market 2018 - Roche Diagnostics, Alere, Siemens Healthc …
The statistical surveying information incorporated into the Rapid Diagnostics report is the aftereffect of significant essential and optional research exercises. The report fragments the worldwide market for Rapid Diagnostics based on makers, item compose, applications, and Region. In this report, each fragment is contemplated completely and measurements are introduced in detail. The report offers an exact outline of the worldwide Rapid Diagnostics advertise covering key factors, for example, drivers and
Influenza Diagnostics Market
Influenza, commonly known as flu, is an infectious disease caused by the influenza virus. Three varieties of this virus affect people: type A, type B, and type C. Influenza spreads through infectious respiratory secretions caused by aerosol formation due to direct contact with an infected person. This virus can cause seasonal epidemics with high levels of morbidity and mortality. According to WHO, these epidemics were estimated to result in about